genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Verily Joins Novartis, Otsuka, Pfizer, and Sanofi in Clinical Trial Alliance
News
Alzheimer’s Map Shows Where Epigenetics Takes Wrong Turn
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding…
News
Insulin-Producing Beta Cells Proliferate When the Brakes Are Off
News
Esophageal Cancer Therapy Using Glutaminase Inhibitors
Insights
Artificial Intelligence
Hey Google. Is This Lung Cancer?
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
A-Lists
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Verily Joins Novartis, Otsuka, Pfizer, and Sanofi in Clinical Trial Alliance
News
Alzheimer’s Map Shows Where Epigenetics Takes Wrong Turn
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding…
News
Insulin-Producing Beta Cells Proliferate When the Brakes Are Off
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
Merck & Co
Merck & Co
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding Late-Stage Kidney Cancer Candidate
Merck & Co
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
Merck & Co
Merck & Co. Plans Jobs Cuts, Shutdowns in Up-to-$1.2B Manufacturing Restructuring
Merck & Co
Merck, King’s Launch $344M+ Chronic Pain Drug Collaboration
Merck & Co
Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline
Merck & Co
Merck & Co. Partners with Sutro on Cytokine Derivatives for Cancer,...
Merck & Co
Merck Invests $125M in Moderna in Expanded mRNA Cancer Vaccine Partnership
Merck & Co
Incyte, Merck & Co. Halt Phase III Trial After Epacadostat/Keytruda Combination...
Merck & Co
Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership
Merck & Co
Merck to Acquire Oncolytic Immunotherapy Developer Viralytics for $394M
Merck & Co
Moderna Raises $500M Financing for mRNA R&D, Manufacturing
Merck & Co
Menlo Therapeutics Files for Up-to-$97.75M IPO
Merck & Co
Merck to Acquire Rigontec, Expanding Cancer Immunotherapy Franchise
Merck & Co
AstraZeneca, Merck Seal Cancer Drug Development Deal Worth Up to $8.5B
Merck & Co
Merck, Samsung Bioepis Launch Remicade Biosimilar in U.S.
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
